Acceptability and accessibility of a shigellosis vaccine in Nha Trang City of Viet Nam

Journal of Health, Population and Nutrition

Volumn 22, Issue 2, 2004, Pages 150-158

  Kaljee, Linda M ^a   Genberg, Becky L ^a   von Seidlein, Lorenz ^b   Canh, Do Gia ^c   Thoa, Le Thi Kim ^d   Thiem, Vu Dinh ^c   Tho, Le Huu ^e   Minh, Truong Tan ^e   Trach, Dang Duc ^c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b International Vaccine Institute   (South Korea)

^c National Institute of Hygiene and Epidemiology   (Viet Nam)

^d Faculty of Electronic and Telecommunication   (Viet Nam)

^e Khanh Hoa Provincial Health Services   (Viet Nam)

Author keywords

Bacillary; Dysentery; Perceptions; Shigella; Vaccination; Viet Nam

Indexed keywords

SHIGELLA VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; AUDIOVISUAL EQUIPMENT; CHILD; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEALTH CARE ACCESS; HEALTH CARE PERSONNEL; HEALTH CENTER; HEALTH PROMOTION; HEALTH SURVEY; HUMAN; INFORMATION DISSEMINATION; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT EDUCATION; PROFESSIONAL PRACTICE; PUBLICATION; SHIGELLOSIS; URBAN AREA; VACCINATION; VERBAL COMMUNICATION; VERBALIZATION; VULNERABLE POPULATION;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; DYSENTERY, BACILLARY; FEMALE; HEALTH CARE SURVEYS; HEALTH PROMOTION; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; POPULATION SURVEILLANCE; PUBLIC HEALTH; RISK FACTORS; SEX FACTORS; SHIGELLA VACCINES; VIETNAM;

SHIGELLA;

EID: 4444326188     PISSN: 16060997     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Kotloff KL, Winickoff JP, Ivanoff B, Clemens JD, Swerdlow DL, Sansonetti PJ et al. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull World Health Organ 1999;77:651-66.
2. Isenbarger DW, Hoge CW, Srijan A, Pitarangsi C, Vithayasai N, Bodhidatta L et al. Comparative antibiotic resistance of diarrheal pathogens from Vietnam and Thailand, 1996-1999. Emerg Infect Dis 2002;8:175-80.
3. Anh NT, Cam PD, Dalsgaard A. Antimicrobial resistance of Shigella spp. isolated from diarrheal patients between 1989 and 1998 in Vietnam. Southeast Asian J Trop Med Public Health 2001;32:856-62.
4. Mel DM, Terzin AL, Vuksic L. Studies on vaccina-tion against bacillary dysentery. 1. Immunization of mice against experimental Shigella infection. Bull World Health Organ 1965;32:633-6.
5. 2a-Sonnei (FS) dysentery vaccine. J Biolog Products 1999; 12:178-80.
6. Taylor DN, Trofa AC, Sadoff J, Chu C, Bryla D, Shiloach J et al. Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoids. Infect Immun 1993;61:3678-87.
7. Cohen D, Ashkenazi S, Green MS, Gdalevich M, Robin G, Slepon R et al. Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults. Lancet 1997;349:155-9.
8. Levenson VI, Belkin ZP, Egorova TP, Liubinskaia MM, Sazykina S. [The immunogenic and serological properties of the O-specific polysaccharide (L-hapten) in Shigella]. Zh Mikrobiol Epidemiol Immunobiol 1991;8:5-9.
9. Nichter M. Vaccinations in the third world: a consideration of community demand. In: Nichter M, Nicher M, editors. Anthropology and international health: Asian case studies. Amsterdam: Gordon and Breach, 2000:329-66.
10. Pielak KL, Hilton A. University students immunized and not immunized for measles: a comparison of beliefs, attitudes, and perceived barriers and benefits. Can J Public Health 2003;94:193-6.
11. Zimet GD, Liau A, Fortenberry VD. Health beliefs and intention to get immunized for HIV. J Adolesc Health 1997;20:354-59.
12. Bond L, Nolan T, Pattison P, Carlin J. Vaccine preventable diseases and immunizations: a qualitative study of mothers' perceptions of severity, susceptibility, benefits and barriers. Aust N Z J Public Health 1998;22:441-6.
13. Tarrant M, Gregory D. Exploring childhood immunization uptake with First Nations mothers in northwestern Ontario, Canada. J Adv Nurs 2003; 4:63-72.
14. SPSS: Statistical Package for Social Sciences for Windows. New York: McGraw-Hill, 1975. 675 p.
15. Stata (Stata Statistical Software). Texas: Stata Corporation, 1995. 565 p.
16. Trach DD, Clemens JD, Ke NT, Thuy HT, Son ND, Canh DG et al. Field trial of a locally produced, killed, oral cholera vaccine in Viet Nam. Lancet 1997;349:231-5.
17. Naficy AB, Trach DD, Ke NT, Chuc NT, Sorkin A, Rao MR et al. Cost of immunization with a locally produced, oral cholera vaccine in Viet Nam. Vaccine 2001;19:3720-5.